National Cancer Institute Recruiting Patients with Rare Cancers for Immunotherapy Trial – Lymphoma News Today
Lymphoma News Today |
National Cancer Institute Recruiting Patients with Rare Cancers for Immunotherapy Trial
Lymphoma News Today The National Cancer Institute (NCI) is conducting the first federally funded immunotherapy trial devoted to rare cancers. Such cancers occur in only six of 100,000 people per year. Anyone in this category can join the nationwide trial, which is called … |
